Dallas, TX - In a study hailed as the "first rigorous analysis of the costs of brachytherapy," Dr David J Cohen (Beth Israel Deaconess Medical Center, Boston, MA) and colleagues report that the cost ...

WASHINGTON, D.C. - (October 17, 2005) - Results from the SISR trial, a multi-center, randomized study of the CYPHER(r) Sirolimus-eluting Coronary Stent versus radiation from within a vessel ...

In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Patients who develop in-stent restenosis (ISR) are at a very high risk of recurrence after conventional balloon angioplasty. The use of repeat bare metal stent implantation has not made a significant ...

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for ...